Abstract |
In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin, pristinamycin, and the pristinamycin compounds, P1 and P2, were determined by a dye uptake assay and a plaque assay. The MICs were 1 microgram/ml for roxithromycin, 2 micrograms/ml for pristinamycin, greater than 256 micrograms/ml for P1, and 2 micrograms/ml for P2. Compounds P1 and P2 did not share synergetic activity. The toxicity of each compound was determined by a dye uptake assay. Toxic concentrations were 128 micrograms/ml for roxithromycin, 32 micrograms/ml for pristinamycin, greater than 256 micrograms/ml for P1, and 32 micrograms/ml for P2. Roxithromycin and pristinamycin could be useful in the treatment of Rocky Mountain spotted fever and Mediterranean spotted fever.
|
Authors | M Drancourt, D Raoult |
Journal | Antimicrobial agents and chemotherapy
(Antimicrob Agents Chemother)
Vol. 33
Issue 12
Pg. 2146-8
(Dec 1989)
ISSN: 0066-4804 [Print] United States |
PMID | 2515795
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Peptides, Cyclic
- Virginiamycin
- Roxithromycin
|
Topics |
- Animals
- Anti-Bacterial Agents
(pharmacology, toxicity)
- Microbial Sensitivity Tests
- Peptides, Cyclic
(pharmacology, toxicity)
- Rickettsia
(drug effects)
- Rickettsia rickettsii
(drug effects)
- Roxithromycin
(pharmacology, toxicity)
- Vero Cells
(drug effects)
- Virginiamycin
|